Literature DB >> 22267620

Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?

Almundher Al-Maawali, Asnat Walfisch, Gideon Koren.   

Abstract

QUESTION: One of my 35-year-old pregnant patients has been treated with enalapril for primary hypertension. She learned she was pregnant at 11 weeks' gestation. I read somewhere that angiotensin-converting enzyme (ACE) inhibitors can cause malformations. What advice do you give to Motherisk callers? ANSWER: Most published studies have failed to show an effect of ACE inhibitors on congenital malformations. A recent systematic review and meta-analysis conducted by Motherisk does not suggest increased fetal risk of malformations. However, ACE inhibitors should be avoided in late pregnancy, as they might cause renal failure and acalvaria in the baby.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267620      PMCID: PMC3264010     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  20 in total

Review 1.  Taking ACE inhibitors during pregnancy. Is it safe?

Authors:  Savithiri Ratnapalan; Gideon Koren
Journal:  Can Fam Physician       Date:  2002-06       Impact factor: 3.275

Review 2.  Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.

Authors:  Albert Quan
Journal:  Early Hum Dev       Date:  2006-01-19       Impact factor: 2.079

Review 3.  Angiotensin converting enzyme inhibitors in pregnancy.

Authors:  J M Mastrobattista
Journal:  Semin Perinatol       Date:  1997-04       Impact factor: 3.300

4.  From the Centers for Disease Control and Prevention. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.

Authors: 
Journal:  JAMA       Date:  1997-04-16       Impact factor: 56.272

5.  Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases.

Authors:  Raphael Serreau; Dominique Luton; Marie-Alice Macher; Anne-Lise Delezoide; Catherine Garel; Evelyne Jacqz-Aigrain
Journal:  BJOG       Date:  2005-06       Impact factor: 6.531

6.  Placental passage of angiotensin-converting enzyme inhibitors.

Authors:  K Reisenberger; C Egarter; B Sternberger; P Eckenberger; E Eberle; E R Weissenbacher
Journal:  Am J Obstet Gynecol       Date:  1996-05       Impact factor: 8.661

7.  Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Authors:  E Boix; P Zapater; A Picó; O Moreno
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

8.  Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment.

Authors:  Sonia Tabacova; Ruth Little; Yi Tsong; Amarilys Vega; Carole A Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-12       Impact factor: 2.890

9.  Association between maternal obesity and fetal cardiac malformations in African Americans.

Authors:  Lyrée N Mikhail; Cheryl K Walker; Robert Mittendorf
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

10.  Angiotensin-converting enzyme inhibitor fetopathy.

Authors:  P G Pryde; A B Sedman; C E Nugent; M Barr
Journal:  J Am Soc Nephrol       Date:  1993-03       Impact factor: 10.121

View more
  3 in total

Review 1.  Hypertension and Pregnancy.

Authors:  Carol Lai; Stephanie A Coulter; Amy Woodruff
Journal:  Tex Heart Inst J       Date:  2017-10-01

2.  Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans.

Authors:  Sanket S Dhruva; James Dziura; Harini Bathulapalli; Lindsey Rosman; Allison E Gaffey; Melinda B Davis; Cynthia A Brandt; Sally G Haskell
Journal:  J Gen Intern Med       Date:  2022-08-30       Impact factor: 6.473

Review 3.  Modeling congenital kidney diseases in Xenopus laevis.

Authors:  Alexandria T M Blackburn; Rachel K Miller
Journal:  Dis Model Mech       Date:  2019-04-09       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.